Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Join Sanguine's Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) patient community to stay informed on upcoming trials
Join Sanguine's Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) patient community to stay informed on upcoming trials

We Bring Research To You

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) also known as Arrhythmogenic Right Ventricular Dysplasia (ARVD) is a disease that affects the normal electrical signaling in the heart, resulting in abnormal heart rhythms (arrhythmias). ARVC/D can also affect the heart muscle in the ventricles (lower pumping chambers), making it harder for the heart to pump blood to the rest of the body. is a rare condition that causes an abnormal protein called amyloid to build up in the organs, which leads to organ damage. Better medicine and treatment options are needed for ARVC/D in order to save thousands of people each year.

We believe patients like you are the key to making a difference in ARVC/D research. Joining a research study can help advance the future of ARVC/D research and impact the development of new treatments and cures.

Sanguine's unique model alleviates many of the difficulties associated with clinical trials and we make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel. Sign up to learn more and participate today!

Sanguine's Expertise in Accelerating Research

25,000+
Members in
our community
3
Average # of times a
member has participated
500+
Studies completed
by Sanguine

We are currently recruiting for 1 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) study

STUDY NAME:

At-Home Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Research Study

compensation:

$50

description

Volunteers with arrhythmogenic right ventricular cardiomyopathy (ARVC) are needed to participate in a research study from the comfort of their own home. The main purpose of this study is to collect blood samples from volunteers to be used in various research studies at Cydan II, Inc. (Cydan). Your blood may assist researchers in developing a new treatment for arrhythmogenic right ventricular cardiomyopathy also known as arrhythmogenic right ventricular dysplasia (ARVC/D).

location

United States

RECRUITMENT FOR THIS STUDY CLOSES IN:
THE STUDY IS NOW CLOSED

Nationwide Partners

We partner with these like-minded organizations and nonprofits to connect with patients who want to contribute and help accelerate research.

Join the Sanguine community!